LISATA THERAPEUTICS, INC. Proceeds from Issuance of Warrants
LISATA THERAPEUTICS, INC. (LSTA) reported Proceeds from Issuance of Warrants of $1.00 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2018-03-22
- LISATA THERAPEUTICS, INC. proceeds from issuance of warrants for the quarter ending 2016-03-31 was $1.00M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 3 month |
|---|---|---|
| 2016-03-31 | $1.00M 10-Q · filed 2016-11-07 | |
| 2016-03-10 | $1.00M 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |